Your browser doesn't support javascript.
loading
Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer's Disease Patients.
Bartolomé, Fernando; Rosa, Luigi; Valenti, Piera; Lopera, Francisco; Hernández-Gallego, Jesús; Cantero, José Luis; Orive, Gorka; Carro, Eva.
Afiliação
  • Bartolomé F; Group of Neurodegenerative Diseases, Hospital Universitario 12 de Octubre Research Institute (imas12), Madrid, Spain.
  • Rosa L; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Valenti P; Department of Public Health and Infectious Diseases, University of Rome "La Sapienza", Rome, Italy.
  • Lopera F; Department of Public Health and Infectious Diseases, University of Rome "La Sapienza", Rome, Italy.
  • Hernández-Gallego J; Neuroscience Group of Antioquia, Faculty of Medicine, University of Antioquia, Medellín, Colombia.
  • Cantero JL; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Orive G; Department of Neurology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Carro E; Department of Medicine, Faculty of Medicine, Complutense University of Madrid, Madrid, Spain.
Front Immunol ; 13: 878201, 2022.
Article em En | MEDLINE | ID: mdl-35547737
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / COVID-19 / Tratamento Farmacológico da COVID-19 Limite: Aged / Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / COVID-19 / Tratamento Farmacológico da COVID-19 Limite: Aged / Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article